| Nov 14 |
Biora Therapeutics GAAP EPS of -$5.04 misses by $1.19, revenue of $0.03M
|
| Nov 14 |
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
|
| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 13 |
Biora Therapeutics Q3 Earnings Preview
|
| Oct 29 |
Biora Therapeutics stock falls as it looks to raise $3M via direct offering
|
| Oct 29 |
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Oct 14 |
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
|
| Oct 7 |
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
|
| Aug 26 |
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 15 |
BIOR: Second Quarter Results
|
